PDX1

Background: This peptide is the immunogen used to make Cat # X2755P.

Activates insulin, somatostatin, glucokinase, islet amyloid polypeptide and glucose transporter type 2 gene transcription. Particularly involved in glucose-dependent regulation of insulin gene transcription. As part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Binds preferentially the DNA motif 5'-[CT]TAAT[TG]-3'. During development, specifies the early pancreatic epithelium, permitting its proliferation, branching and subsequent differentiation. At adult stage, required for maintaining the hormone-producing phenotype of the beta-cell.
Blocking Peptide to Cat # X2755P.

Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide.

Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.

• Artikelnummer: EXAX2770B
• Hersteller: Exalpha Biologicals Inc
• Hersteller Artikelnummer: X2770B
• Verpackungseinheit: 50 µg
• Mengeneinheit: STK
• Methode: Others